HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Mammography

Mammography is a crucial diagnostic imaging technique specifically designed for breast examination, offering an effective means for early detection of breast cancer. This specialized X-ray imaging involves compressing the breast tissue to obtain detailed and high-resolution images of the internal structures. Digital mammography has largely replaced traditional film mammography, providing enhanced image quality and allowing for easier storage and retrieval of images. Mammograms are primarily used for routine breast cancer screening in asymptomatic women, aiding in the identification of suspicious masses, microcalcifications, and other abnormalities that may indicate the presence of breast cancer. As a frontline tool in breast cancer detection, mammography plays a pivotal role in improving patient outcomes through early intervention. Regular screening mammograms are recommended for women over the age of 40 and may be initiated earlier for those with a family history of breast cancer. Diagnostic mammography is employed when additional evaluation is needed following an abnormal screening result or when a woman experiences symptoms such as breast pain or a palpable lump.

The integration of digital breast tomosynthesis (DBT), often referred to as 3D mammography, further enhances mammographic capabilities by capturing multiple images from various angles, reducing overlapping tissue artifacts and providing a more detailed three-dimensional view of breast structures. Continued research and technological advancements in mammography are focused on improving sensitivity and specificity, reducing radiation exposure, and developing adjunct technologies for breast cancer diagnosis. Innovations such as contrast-enhanced mammography and automated breast ultrasound aim to supplement mammography in specific clinical scenarios. With ongoing efforts to refine and expand mammographic capabilities, this imaging modality remains an indispensable tool in the comprehensive approach to breast cancer screening, early diagnosis, and overall breast health management.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp